US authorises Pfizer oral Covid-19 pill Paxlovid for home treatment
SCMP, 23 Dec 2021
Subscribe to our YouTube channel for free here:
https://sc.mp/subscribe-youtube
The US Food and Drug Administration on December 22, 2021, approved the use of Pfizer’s Paxlovid pill for emergency use for treating mild-to-moderate disease in Covid-19 patients aged 12 or older. Pfizer’s clinical data shows the drug is 90 per cent effective in preventing hospitalisations and deaths in patients at high risk of severe illness. Paxlovid is the first at-home oral drug that has been approved to treat Covid-19.
Support us:
https://subscribe.scmp.com
Follow us on:
Website: https://www.scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
#scmp #Coronavirus
https://sc.mp/subscribe-youtube
The US Food and Drug Administration on December 22, 2021, approved the use of Pfizer’s Paxlovid pill for emergency use for treating mild-to-moderate disease in Covid-19 patients aged 12 or older. Pfizer’s clinical data shows the drug is 90 per cent effective in preventing hospitalisations and deaths in patients at high risk of severe illness. Paxlovid is the first at-home oral drug that has been approved to treat Covid-19.
Support us:
https://subscribe.scmp.com
Follow us on:
Website: https://www.scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
#scmp #Coronavirus
